Iterative surgical resection of a recurrent gallbladder carcinoma with long-term survival: report of a case. by Scaringi, S et al.
Abstract. Gallbladder carcinoma is a rare, but often lethal
disease. Unfortunately, at the time of diagnosis, patients
usually have advanced disease (T3-T4) and long-term
survival is dismal, ranging from 5 to 12% in the literature.
However, this cancer can be successfully treated when the
tumour is organ-confined (T1-T2 tumours), as happens in the
case of incidental diagnosis at the time of cholecystectomy
for gallstones. Here we describe a patient with recurrent
gallbladder carcinoma who, treated with iterative surgical
resection, is alive and disease-free at 5 years after the final
surgical procedure.
Gallbladder carcinoma is a rare, but often lethal disease. It
represents the fifth most common gastrointestinal
malignancy and the most common biliary tract cancer.
Considering the ineffectiveness of chemotherapy and
radiotherapy as first-line treatment, surgery remains the only
chance for cure. Unfortunately, at the time of diagnosis,
patients usually have advanced disease (T3-T4) and, despite
technological improvements in hepato-biliary surgery, only
15-47% are candidates for resection (1-3). Overall long-term
survival is dismal, ranging from 5 to 12% in the literature
(4). However, this cancer can be successfully treated when
the tumour is organ-confined (T1-T2 tumours), as happens
in the case of incidental diagnosis at the time of
cholecystectomy for gallstones. Conversely, when recurrence
takes place, prognosis is very poor, and no survival beyond 5
years is reported (5).
We describe the case of a patient affected with recurrent
gallbladder carcinoma who, treated with iterative surgical
resection, is alive and disease-free at 5 years after the final
surgical procedure.
Case Report
A 73-year-old woman presented in October 2001 with
abdominal pain. For 3 months she had been suffering from
steady pain, episodically acute, located in the upper right
abdominal quadrant, which gradually subsided after a few
hours. It was associated with vomiting, but with no fever or
jaundice. She did not complain of loss of appetite or weight, nor
changes in bowel habits. Her past history was unremarkable.
On physical examination, the abdomen was tender to
palpation in the epigastric and upper right quadrant.
Murphy’s sign was negative. The leukocyte count, serum
bilirubin, alkaline phosphatase and amylase were within
normal values. Sonography showed multiple gallstones
without thickening of the gallbladder wall or dilatation of the
common bile duct. One week later, elective laparoscopic
cholecystectomy was carried out. The gallbladder was not
opened during the procedure, but extracted through an
endobag. No frozen sections were performed. Pathological
examination revealed the presence of a polypoid tumour of 2
cm in diameter, located in the fundus of the gallbladder,
corresponding to a poorly differentiated adenocarcinoma
infiltrating the muscle layer (pT2/Nx/Mx) (Figure 1A).
Liver resection of the gallbladder bed and lymph node
dissection of the hepatic pedicle was proposed but the patient
refused, accepting, however, adjuvant chemotherapy with
fluorouracil and leucovorin, according to the de Gramont
schedule (6). This was interrupted after 4 cycles because
herpes zoster had occurred. The patient was followed up
every six months with clinical examination, CT scan and
biological markers. In October 2002, CT showed a single 4-
cm lesion in the inferior splenic pole, suggestive of
metastasis (Figure 2-A). Biological markers were in the
normal range. The patient underwent splenectomy and lymph
node dissection of the hepatic pedicle. The postoperative
course was uneventful; pathology revealed metastasis of
poorly differentiated adenocarcinoma matching the primary
tumour of the gallbladder (Figure 2B). Lymph nodes of the
hepatic pedicle were free of disease. No further adjuvant
treatment was administered.
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Figure 3. A: CT scan showing the recurrence involving the pancreatic tail and the greater curvature of the stomach (white arrow); B: poorly
differentiated adenocarcinoma infiltrating the external layer of the gastric wall.
Figure 2. A: CT scan showing the metastasis at the inferior splenic pole (white arrow); B: parenchymal intravascular emboli with integrity of the
splenic capsule.
Figure 1. A: Poorly differentiated adenocarcinoma infiltrating the muscle layer; B: intense immunoreactivity with cytokeratin-7; C-D: markers of
neuroendocrine tumours, chromogranin and synaptophysin, are negative.
In March 2003, a CT scan showed a solitary lesion of 2.5 cm
in diameter involving the pancreatic tail and the greater
curvature of the stomach, indicative of recurrence (Figure 3A).
The patient was then subjected to distal pancreatectomy en-bloc
with sleeve gastrectomy and omentectomy. Portal-sites were not
excised. Pathology confirmed metastasis of poorly differentiated
adenocarcinoma infiltrating the external layer of the gastric wall
(Figure 3B). Five years later the patient is alive without
evidence of recurrence.
Discussion 
Long-term survival of a patient with metachronous
metastasis of primary gallbladder carcinoma is an uncommon
event, never previously reported in the literature.
Gallbladder carcinoma is a tumour with an aggressive
biological behaviour and poor prognosis. Patients are often
diagnosed at advanced stage and surgical resection is the
only possibility of cure, with survival rates ranging from 5%
to 12% at 5 years (4, 7). Nevertheless, a different assessment
should be made for tumours diagnosed incidentally after
laparoscopic cholecystectomy. They often present at an early
stage (T1/T2) with a 5-year survival of 85% for T1 tumours
operated with simple cholecystectomy, and 61% for T2
tumours, if promptly re-operated and liver resection
performed (usually segments IVb-V), along with lymph node
dissection of the hepatic pedicle (8, 9). Notably, the presence
of nodal metastasis at this site is the most important factor
to influence survival, as reported by Lin et al. (9). Moreover,
a recent review described how the presence of residual
disease and the ability to achieve R0 represent significant
prognostic factors (10).
In the current case, pathology revealed a T2 primary
tumour, while the nodal dissection of the hepatic pedicle,
performed at the time of the second operation, gave no
evidence of metastasis. We hypothesise that these features
influenced the patient’s outcome positively. It is worth
emphasising that the splenic recurrence was a true vascular
metastasis rather than a peritoneal implantation, as proven by
the presence of parenchymal intravascular emboli and the
integrity of the splenic capsule. However, the physio-
pathological mechanisms of tumour vascular spread to the
spleen, in the absence of portal hypertension, still remain
unclear. Indeed, no report has been found in the literature
concerning splenic metastasis from T2 gallbladder carcinomas. 
On histological examination, poorly differentiated
carcinomas of the gallbladder may exhibit various growth
patterns. In some instances, neoplastic cells form cords and
nests, or they infiltrate simply as individual cells. A diffuse
sheet-like component may be seen, as in our case.
Immunohistochemically, stains for cytokeratin 7 (Figure 1B),
and carcino-embryonic antigen show intense immunoreactivity
in a dominant population of tumour cells. Several mucin-
related glycoproteins, such as MUC1 and MUC5AC, are also
normally expressed, although they may be focal, while general
markers of neuroendocrine differentiation, such as neuron-
specific enolase (NSE), chromogranins and synaptophysin, are
invariably negative (Figure 1-C,D).
As regards treatment of gallbladder carcinoma, it is
common opinion that adjuvant therapy plays a marginal role.
In a recent review, chemotherapy was considered only
palliative in non-resectable or metastatic tumours, and the
authors concluded that no single or combined regimens
should be recommended as a standard of care (5).
This report suggests that surgical resection of solitary
metachronous metastasis should not be excluded as
therapeutic approach, even for gallbladder carcinoma, which
should not represent a predetermined condition in case of
organ confined tumours (T1-T2).
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